Farther Finance Advisors, LLC Innate Pharma Sa Transaction History
Farther Finance Advisors, LLC
- $6.63 Trillion
- Q3 2025
A detailed history of Farther Finance Advisors, LLC transactions in Innate Pharma Sa stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 10 shares of IPHA stock, worth $19. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10Holding current value
$19% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IPHA
# of Institutions
11Shares Held
98.7KCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY51.2KShares$100,9110.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il26.6KShares$52,4350.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny11.7KShares$22,9720.0% of portfolio
-
Ubs Group Ag5.96KShares$11,7350.0% of portfolio
-
Gamma Investing LLC Foster City, CA2.28KShares$4,4930.0% of portfolio
About Innate Pharma SA
- Ticker IPHA
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 79,893,000
- Market Cap $157M
- Description
- Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and periphera...